These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2511607)

  • 1. [Prostacyclin, EDRF and arteriosclerosis].
    Gryglewski R; Korbut R; Dembińska-Kieć A
    Przegl Lek; 1989; 46(7):543-6. PubMed ID: 2511607
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vascular endothelium in the processes of hemostasis and thrombosis. The role of prostacyclin and EDRF].
    Radomski MW
    Acta Physiol Pol; 1989; 40 Suppl 33():97-109. PubMed ID: 2489269
    [No Abstract]   [Full Text] [Related]  

  • 3. [Disorders of arachidonic acid metabolism in experimental arteriosclerosis].
    Dembińska-Kieć A
    Pol Tyg Lek; 1982 Jul; 37(22):647-51. PubMed ID: 6294641
    [No Abstract]   [Full Text] [Related]  

  • 4. [New theories on the role of chylomicrons (alimentary lipemia) in the etiopathogenesis of arteriosclerosis].
    Mirkiewicz E; Naruszewicz M
    Kardiol Pol; 1987; 30(6):337-45. PubMed ID: 3312757
    [No Abstract]   [Full Text] [Related]  

  • 5. Vasoactive mediators derived from the endothelium.
    Botting R; Vane JR
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():11-4. PubMed ID: 2514650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of nitric oxide and prostacyclin synthesis in endothelial cells.
    Busse R; Hecker M; Fleming I
    Arzneimittelforschung; 1994 Mar; 44(3A):392-6. PubMed ID: 8185712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary-fat-induced changes in the formation of prostanoids of the 2 and 3 series in relation to arterial thrombosis (rat) and atherosclerosis (rabbit).
    Hornstra G; Haddeman E; Kloeze J; Verschuren PM
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():193-202. PubMed ID: 6221593
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostacyclin-induced relaxations of small porcine pulmonary arteries are enhanced by the basal release of endothelium-derived nitric oxide through an effect on cyclic GMP-inhibited-cyclic AMP phosphodiesterase.
    Zellers TM; Wu YQ; McCormick J; Vanhoutte PM
    Acta Pharmacol Sin; 2000 Feb; 21(2):131-8. PubMed ID: 11263259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypotheses with regard to the etiology of arteriosclerosis: contradictions and similarities].
    Tatoń J
    Pol Tyg Lek; 1982 Jul; 37(22):629-32. PubMed ID: 6757900
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostacyclin synthesis in human and experimental atherosclerosis.
    Sinzinger H; Clopath P; Silberbauer K; Auerswald W
    Atherosclerosis; 1979 Nov; 34(3):345-7. PubMed ID: 391250
    [No Abstract]   [Full Text] [Related]  

  • 11. Toxicological effects of beryllium on platelets and vascular endothelium.
    Togna G; Togna AR; Russo P; Caprino L
    Toxicol Appl Pharmacol; 1997 Jun; 144(2):262-7. PubMed ID: 9194409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Croonian Lecture, 1993. The endothelium: maestro of the blood circulation.
    Vane JR
    Philos Trans R Soc Lond B Biol Sci; 1994 Jan; 343(1304):225-46. PubMed ID: 8146236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostacyclin production and atherosclerosis of the rabbit aorta.
    Voss R; ten Hoor F; Matthias FR
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():469-74. PubMed ID: 6221565
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostacyclin and atherosclerosis--experimental and clinical approaches.
    Gryglewski RJ; Kostka-Trabka E; Demińska-Kieć A; Korbut R
    Adv Exp Med Biol; 1988; 243():21-9. PubMed ID: 3066178
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary endothelial dysfunction: atherosclerosis.
    Shimokawa H
    J Mol Cell Cardiol; 1999 Jan; 31(1):23-37. PubMed ID: 10072713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vasoactive factors of endothelial origin].
    Levesque H; Chassagne P; Moore N; Courtois H
    J Mal Vasc; 1990; 15(4):393-8. PubMed ID: 2286824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Furosemide enhances the release of endothelial kinins, nitric oxide and prostacyclin.
    Wiemer G; Fink E; Linz W; Hropot M; Schölkens BE; Wohlfart P
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1611-5. PubMed ID: 7996475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation by the endothelium of prostacyclin, nitric oxide and endothelin.
    Vane JR; Botting RM
    J Lipid Mediat; 1993; 6(1-3):395-404. PubMed ID: 8357997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of nitric oxide and prostacyclin as vasoactive hormones released by the endothelium.
    Mitchell JA; Ali F; Bailey L; Moreno L; Harrington LS
    Exp Physiol; 2008 Jan; 93(1):141-7. PubMed ID: 17965142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Disorders of arachidonic acid metabolism in experimental arteriosclerosis].
    Dembińska-Kieć A
    Folia Med Cracov; 1982-1983; 24(1-2):119-40. PubMed ID: 6315549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.